公司概覽
業務類別 Biotechnology
業務概覽 Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
公司地址 200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
電話號碼 +1 267 824-2827
傳真號碼 --
公司網頁 https://www.madrigalpharma.com
員工數量 915
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. William John Sibold Director, President and Chief Executive Officer 美元 918.53K 28/04/2026
Ms. Mardi C. Dier Executive Vice President and Chief Financial Officer 美元 566.04K 28/04/2026
Dr. David Soergel, M.D. Executive Vice President and Chief Medical Officer 美元 418.18K 28/04/2026
Ms. Carole Huntsman Executive Vice President and Chief Commercial Officer 美元 540.31K 28/04/2026
Ms. Shannon T. Kelley Executive Vice President and Chief Legal Counsel 美元 535.17K 28/04/2026
Ms. Rita Thakkar Senior Vice President and Chief Accounting Officer -- 12/03/2026
 
董事會成員
董事會 職務 更新日期
Dr. John C. Reed,M.D.,PhD Director 12/08/2026
Mr. Julian C. Baker Chairman of the Board 28/04/2026
Dr. Jacqualyn A. Fouse, PhD Independent Director 28/04/2026
Dr. Rebecca A. Taub,M.D. Director 28/04/2026
Dr. Richard S. Levy,M.D. Independent Director 28/04/2026
Mr. Daniel J. Brennan Independent Director 28/04/2026
Mr. William John Sibold Director, President and Chief Executive Officer 28/04/2026
Mr. James M. Daly Independent Director 28/04/2026
Dr. Raymond Cheong, M.D. Independent Director 28/04/2026
 
所屬ETF (更新日期: 14/11/2026 02:04)
代號 名稱 佔比% ▼ 持有日期
TNXTT. Rowe Price Innovation Leaders ETF0.0002%31/10/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%30/10/2026
MNZLManzil Russell Halal USA Broad MarketETF0.0001%30/10/2026
HQGOHartford US Quality Growth ETF0.0001%31/10/2026
FSEGFidelity Enhanced Small Cap Growth ETF0.0001%30/10/2026
REMCColumbia Research Enhanced Mid Cap ETF0.00004%31/10/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.00003%30/10/2026
QQHGInvesco QQQ Hedged Advantage ETF0.00003%30/10/2026
RADDAB US Research Advanced ETF0.00002%30/10/2026
FEMGFidelity Enhanced Mid Cap Growth ETF0.00001%30/10/2026
RECIColumbia Research Enhanced Cor PrmIncETF0.00001%31/10/2026
AAUBAlpha Architect US Equity 4 ETF<0.000001%28/08/2026
AFMCFirst Trust Active Factor Mid Cap ETF<0.000001%24/02/2026
AGOXAdaptive Alpha Opportunities ETF<0.000001%01/08/2025
AIEQAI Powered Equity ETF<0.000001%10/05/2023
AVSUAvantis Responsible US Equity ETF<0.000001%06/06/2026
BRESBurney U.S. Equity Select ETF<0.000001%15/07/2026
DCORDimensional US Core Equity 1 ETF<0.000001%17/08/2026
DFACDimensional US Core Equity 2 ETF<0.000001%05/08/2026
DFAUDimensional US Core Equity Market ETF<0.000001%24/08/2026
  1    2    3    4   5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.